Reis CP et al. |
Design of polymeric nanoparticles and its applications as drug delivery systems for acne treatment. |
2014 |
Drug Dev Ind Pharm |
pmid:23480566
|
Wang HW et al. |
Insight into the molecular evolution of non-specific lipid transfer proteins via comparative analysis between rice and sorghum. |
2012 |
DNA Res. |
pmid:22368182
|
Sarkar R et al. |
A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients. |
2002 |
Dermatology (Basel) |
pmid:12399672
|
Hermanns JF et al. |
Unraveling the patterns of subclinical pheomelanin-enriched facial hyperpigmentation: effect of depigmenting agents. |
2000 |
Dermatology (Basel) |
pmid:11053913
|
Gollnick HP and Krautheim A |
Topical treatment in acne: current status and future aspects. |
2003 |
Dermatology (Basel) |
pmid:12566803
|
Brasch J and Christophers E |
Azelaic acid has antimycotic properties in vitro. |
1993 |
Dermatology (Basel) |
pmid:8435518
|
Gollnick H and Schramm M |
Topical drug treatment in acne. |
1998 |
Dermatology (Basel) |
pmid:9557245
|
Hermanns JF et al. |
Assessment of topical hypopigmenting agents on solar lentigines of Asian women. |
2002 |
Dermatology (Basel) |
pmid:12077522
|
Shariff A et al. |
Acne vulgaris in the context of complex medical co-morbities: the management of severe acne vulgaris in a female with retinitis pigmentosa - utilizing pulse dye laser in conjunction with medical therapy. |
2014 |
Dermatol. Online J. |
pmid:24656277
|
Halder RM and Richards GM |
Management of dyschromias in ethnic skin. |
2004 |
Dermatol Ther |
pmid:15113282
|
Cayce KA et al. |
Hyperpigmentation: an overview of the common afflictions. |
2004 |
Dermatol Nurs |
pmid:15624705
|
Gibson JR |
Azelaic acid 20% cream (AZELEX) and the medical management of acne vulgaris. |
1997 |
Dermatol Nurs |
pmid:9392765
|
Prignano F et al. |
Therapeutical approaches in melasma. |
2007 |
Dermatol Clin |
pmid:17662899
|
Ely H |
Dermatologic therapies you've probably never heard of. |
1989 |
Dermatol Clin |
pmid:2646047
|
Del Rosso JQ |
A status report on the medical management of rosacea: focus on topical therapies. |
2002 |
Cutis |
pmid:12469780
|
Wolf JE |
The role of topical metronidazole in the treatment of rosacea. |
2004 |
Cutis |
pmid:14959942
|
Del Rosso JQ |
Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial. |
2010 |
Cutis |
pmid:21229827
|
Del Rosso JQ et al. |
Impact of order of application of moisturizers on percutaneous absorption kinetics: evaluation of sequential application of moisturizer lotions and azelaic acid gel 15% using a human skin model. |
2009 |
Cutis |
pmid:19363903
|
Del Rosso JQ |
The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study. |
2009 |
Cutis |
pmid:19746764
|
Elewski BE |
Rosacea trial comparing twice-daily azelaic acid gel 15% with once-daily metronidazole gel 1%. |
2007 |
Cutis |
pmid:17330623
|
Del Rosso JQ and Bhatia N |
Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application. |
2011 |
Cutis |
pmid:21916272
|
Del Rosso JQ et al. |
Azelaic acid gel 15%: clinical versatility in the treatment of rosacea. |
2006 |
Cutis |
pmid:17354468
|
Colón LE et al. |
Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%. |
2007 |
Cutis |
pmid:17500380
|
Wolf JE |
Present and future rosacea therapy. |
2005 |
Cutis |
pmid:15810803
|
van Zuuren EJ and Graber MA |
The rigor of trials evaluating Rosacea treatments. |
2005 |
Cutis |
pmid:15810805
|
Draelos ZD |
Noxious sensory perceptions in patients with mild to moderate rosacea treated with azelaic acid 15% gel. |
2004 |
Cutis |
pmid:15551720
|
Fleischer AB |
The evolution of azelaic acid. |
2006 |
Cutis |
pmid:16566281
|
Draelos ZD |
The rationale for advancing the formulation of azelaic acid vehicles. |
2006 |
Cutis |
pmid:16566282
|
Elewski B and Thiboutot D |
A clinical overview of azelaic acid. |
2006 |
Cutis |
pmid:16566283
|
Bikowski JB |
Case studies. |
2006 |
Cutis |
pmid:16566284
|
Del Rosso JQ |
The use of topical azelaic acid for common skin disorders other than inflammatory rosacea. |
2006 |
Cutis |
pmid:16566285
|
Wolf JE et al. |
Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea. |
2006 |
Cutis |
pmid:16706244
|
Callender VD |
Considerations for treating acne in ethnic skin. |
2005 |
Cutis |
pmid:16164153
|
Del Rosso JQ et al. |
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea. |
2014 |
Cutis |
pmid:24738094
|
Draelos ZD et al. |
Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study. |
2013 |
Cutis |
pmid:24416747
|
Gibson JR |
Rationale for the development of new topical treatments for acne vulgaris. |
1996 |
Cutis |
pmid:8654127
|
Graupe K et al. |
Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. |
1996 |
Cutis |
pmid:8654128
|
Breathnach AS |
Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies. |
1996 |
Cutis |
pmid:8654129
|
Lowe NJ |
New approaches in dermatology: a clinical profile of azelaic acid. |
1996 |
Cutis |
pmid:8654130
|
Rocamora V et al. |
Amelanotic lentigo maligna melanoma: report of a case and review of the literature. |
1999 |
Cutis |
pmid:10431675
|
Pazoki-Toroudi H et al. |
Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris. |
2011 |
Cutan Ocul Toxicol |
pmid:21612319
|
Shah J |
Plants under attack: systemic signals in defence. |
2009 |
Curr. Opin. Plant Biol. |
pmid:19608451
|
van Zuuren EJ et al. |
Interventions for rosacea. |
2011 |
Cochrane Database Syst Rev |
pmid:21412882
|
van Zuuren EJ et al. |
Interventions for rosacea. |
2015 |
Cochrane Database Syst Rev |
pmid:25919144
|
Samycia M and Lam JM |
Infantile acne. |
2016 |
CMAJ |
pmid:27873756
|
Sowden J et al. |
Malignant melanoma arising in the scar of lupus vulgaris and response to treatment with topical azelaic acid. |
1988 |
Clin. Exp. Dermatol. |
pmid:3256454
|
Nazzaro-Porro M et al. |
A case of recurrent (following surgery x2) invasive malignant melanoma with satellitosis (stage IIIA) successfully resolving after azelaic acid treatment administered by several routes. |
1996 |
Clin. Exp. Dermatol. |
pmid:8959915
|
Breathnach AC et al. |
Azelaic acid therapy in disorders of pigmentation. |
1989 Apr-Jun |
Clin. Dermatol. |
pmid:2667735
|
Capristo E et al. |
A new HPLC method for the direct analysis of triglycerides of dicarboxylic acids in biological samples. |
1999 |
Clin. Chim. Acta |
pmid:10556649
|
Lowe NJ et al. |
Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. |
1998 Sep-Oct |
Clin Ther |
pmid:9829446
|